baber/WOPTO huggingface dataset:
Patent NZ-543922-A (NZ)
Title: Synthetic gene encoding human carcinoembryonic antigen and uses thereof
Inventor: LA MONICA NICOLA
IPC: C07K14/47
Filed: 2004-05-03
Abstract: Synthetic polynucleotides encoding human carcinoembryonic antigen (CEA) are provided, the synthetic polynucleotides being codon-optimized for expression in a human cellular environment. The gene encoding CEA is commonly associated with the development of human carcinomas. Also provided are compositions and methods to elicit or enhance immunity to the protein product expressed by the CEA tumor-associated antigen, wherein aberrant CEA expression is associated with a carcinoma or its development. Further provided are adenoviral vectors and plasmid constructs carrying codon-optimed human CEA and their use in vaccines and pharmaceutical compositions for preventing and treating cancer.
Patent NZ-550695-A (NZ)
Title: Method of altering the alkaloid composition in poppy plants
Inventor: COTTERILL PAUL
IPC: A01H5/00
Filed: 2005-05-06
Abstract: Disclosed are methods of altering the alkaloid composition of a poppy plant comprising the step of applying an effective amount of an acylcyclohexanedion to said poppy plant. In particular said methods of decrease the proportion of morphine and increase the proportion of thebaine/oripavine in said poppy plant.
Patent NZ-553364-A (NZ)
Title: Bouquet enhancing wineglass
Inventor: HINKLE ALLEN J
IPC: B65D1/02
Filed: 2005-03-15
Abstract: A wineglass for enhancing the bouquet of wine is disclosed. The wineglass includes a bowl having a central axis and a bottom region symmetrically disposed about and extending through the central axis. A protrusion is provided which has a central core that attaches to the bottom region of the bowl and extends along the central axis up into the bowl, where the central core terminates in a core free end. At least one ledge is attached to the central core and positioned such that at least a portion of the ledge provides a wine-supporting ledge surface that is intermediate between the central core free end and the bottom region of the bowl.
Patent NZ-553914-A (NZ)
Title: Stable liquid formulations of plasmid DNA at low buffer concentration
Inventor: BLANCHE FRANCIS
IPC: C12N15/10
Filed: 2005-09-19
Abstract: Disclosed is a stable plasmid DNA liquid storage composition comprising a purified plasmid DNA and a buffer solution, wherein the buffer is present at a concentration of less than 2 mM to maintain the pH of said composition between 6 and 9, wherein the composition comprises predominantly supercoiled form of plasmid DNA, and wherein the plasmid DNA is stable at temperatures around 4°C to 25°C.
Patent NZ-556415-A (NZ)
Title: Compositions and methods for the diagnosis and treatment of glioma tumor
Inventor: FRANTZ GRETCHEN
IPC: A61K47/48
Filed: 2002-12-30
Abstract: Disclosed is the use of an antibody that binds to the TAT265 tumour antigen (SEQ ID NO: 9) or its encoding nucleotide sequence (SEQ ID NO: 29), in the preparation of a medicament for therapeutically treating a mammal having a glioma tumour. Further disclosed are methods of diagnosing the presence of a glioma tumour in a mammal by detecting the expression level of a gene encoding a polypeptide at least 90% identical to SEQ ID NO 29 or to a polypeptide encoded by SEQ ID NO 9. A higher level of expression of such a gene is indicative of the presence of a glioma tumour.
Patent NZ-563183-A (NZ)
Title: Therapeutic methods and uses of sapogenins and their derivatives
Inventor: REES DARYL
IPC: C07J/
Filed: 2003-03-27
Abstract: Disclosed herein is a use of one or more active agent selected from: the steroidal sapogenin compounds of formula (I) (wherein the variables are as defined in the specification), all their stereoisomers, unless stereochemically defined, and racemic mixtures, all their pharmaceutically acceptable salts, and all mixtures and combinations thereof in the manufacture of a medicament for the treatment or prevention of: (i) non-cognitive neurodegeneration, (ii) non-cognitive neuromuscular degeneration, (iii) motor-sensory neurodegeneration, or (iv) receptor dysfunction or loss in the absence of cognitive, neural and neuromuscular impairment, in an animal suffering therefrom or susceptible thereto, wherein the particular conditions, disorders or diseases are as described in the specification.
Patent NZ-567241-A (NZ)
Title: Substituted pyrazole compounds
Inventor: XIAO XIAO-YI
IPC: A61K31/4439
Filed: 2006-09-29
Abstract: Disclosed is a pyrimidinyl amine compound selected from formula (I) or a pharmaceutically acceptable salt, ester, amide, salt of an ester or amide or functional derivative thereof, wherein, the substituents are defined in the specification. Also disclosed is a composition comprising said compound, a method of treating a non-human animal comprising administrating said compound and the use of said compound in the manufacture of a medicament for treating an autoimmune disease, inflammatory disease, neurological or neurogenerative disease, cancer, cardiovascular disease, allergy, asthma, or a hormone related disease.
Patent NZ-569793-A (NZ)
Title: Hygiene Building
Inventor: KNOOP GERHARD
IPC: E04H1/12
Filed: 2006-12-20
Abstract: Hygiene building with an outer wall 2 having a multicornered or circular circumferential contour, which surrounds an inner area 3 and at least one access 6, a plurality of hygiene areas 4 provided in the inner area 3 and delimited by side walls 17, which are arranged along the circumferential contour at the outer wall 2 and in each case have at least one fluid inlet and at least one fluid outlet , a central area 5 provided in the inner area 3 and accessible via the access 6, through which the hygiene areas 4 are accessible, at least one sanitary installation 14 connected to one of the fluid inlets and arranged in one of the hygiene areas 4 and a fluid catchment device connected to the fluid outlets , to which fluid can be conducted through the fluid outlets , characterised in that the hygiene building 1 is assembled from a plurality of modules such that it can be dismantled, these comprising at least the outer wall 2, the side walls 17, the sanitary installation 14 and the fluid catchment device and the fluid catchment device has a plurality of fluid catchment containers separable from one another, which are arranged beneath the hygiene areas 4.
Patent NZ-570008-A (NZ)
Title: Detection of ovarian cancer by elevated levels of Bcl-2 in urine
Inventor: KRUK PATRICIA A
IPC: C12Q1/68
Filed: 2007-02-09
Abstract: Disclosed is a method of accurately screening for ovarian cancer in a subject. The method comprises detecting the presence of Bcl-2 in a urine sample using ELISA-based immunoenzymatic detection. A level of Bcl-2 a pre-determined threshold is accurate to distinguish a subject having ovarian cancer from a non-cancerous individual.
Patent NZ-573101-A (NZ)
Title: Forehead pad for respiratory mask
Inventor: LANG BERND CHRISTOPH
IPC: A62B18/02
Filed: 2003-09-05
Abstract: A forehead pad for a respiratory mask includes a base portion 706, one surface 710 of which is to contact the user's forehead, and a support post 705 projecting from the opposite surface of the base portion to engage the pad with the forehead support of the mask. The support post includes a cut-away portion 720, a cylindrical portion 701, a necked down region 703 and a conical head 702. The head 702 removably snap-fits into apertures in the forehead support. The pad might include a pair of pads for either side of the forehead moulded as a single unit 700.
Patent NZ-573565-A (NZ)
Title: Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
Inventor: SALVATI PATRICIA
IPC: A61K31/165
Filed: 2007-06-13
Abstract: Disclosed herein is the use of a compound of formula (I) in the preparation of a medicament for treating a disease or disorder responsive to improvements in cognitive function and for treating cognitive impairment selected from autism, dyslexia, attention deficit hyperactivity disorder, obsessive compulsive disorders, psychosis, Tourette's syndrome, Mild Cognitive Impairment (MCI), and disorders of learning in children, adolescents and adults, Age Associated Memory Impairment, Age Associated Cognitive Decline; with the proviso that said treatment excludes the treatment of dementia, Alzheimer's disease and Parkinson's disease. . Particularly preferred compounds include: (S)-(+)-2-[4-(2-fluorobenzyloxy)-benzylamino]-propanamide; (S)-(+)-2-[4-(3-fluorobenzyloxy)-benzylamino]-propanamide; 2-[4-(3-Fluorobenzyloxy)-benzylamino]-2-(2-fluoropheny1)-acetamide; 2-[4-(2-Fluorobenzylthio)-benzylamino]-propanamide; 2-(4-(2-Thienyloxy)-benzylamino)-propanamide.
Patent NZ-583327-A (NZ)
Title: Plastic molded box with lateral collapsible walls
Inventor: TONTARELLI SERGIO
IPC: B65D6/18
Filed: 2008-03-04
Abstract: Disclosed is a plastic moulded box with parallelepiped structure and rectangular base provided with collapsible lateral walls (3, 4, 5), in which the two longitudinal walls (3, 4) are higher than half of the width of the transversal walls (5). The two longitudinal walls are perfectly aligned on the same horizontal plane when they are collapsed in idle position by means of partial male-female coupling.
Patent NZ-584265-A (NZ)
Title: Enclosure assembly with control clip for a fiber optic cable
Inventor: MULLANEY JULIAN
IPC: G02B6/44
Filed: 2008-08-26
Abstract: Disclosed is an enclosure assembly for use with a fiber optic cable. The cable has a lengthwise cable axis and includes a plurality of optical fibers and a jacket surrounding the optical fibers including an enclosure housing (111) and a cable control clip (150). The enclosure housing defines a chamber to receive the cable. The cable control clip is configured to be inserted through the cable to extend radially between the optical fibers and the jacket to limit contact between the optical fibers and one or more other components of the cable, and to limit displacement of the enclosure housing relative to the cable when the cable control clip is disposed in the chamber.
Patent NZ-584795-A (NZ)
Title: An edge protector for preventing the upward curl of two adjacent cementitous bodies comprises a wall and a capping
Inventor: MOONEY BRIAN JAMES
IPC: B28B23/00
Filed: 2010-04-21
Abstract: Means for protecting set cementitious material comprises a first body of set cementitious material 11, a second body of set cementitious material 12, and an edge protector 1 arranged between the two bodies. The edge protector 1 provides a wall 3 which runs along immediately adjacent sides of the two bodies below the upper surface of each body, and also providing a capping 2 which caps immediately adjacent upper corners of each body so as to substantially prevent upward curl of such corners.
Patent NZ-590757-A (NZ)
Title: Novel imino derivative, process for production of the same, and pesticide comprising the same
Inventor: KAGABU SHINZO
IPC: A01N43/40
Filed: 2009-07-01
Abstract: Disclosed is an imino derivative which can be used as a pesticidal compound having excellent properties including long-acting efficacy and a broad spectrum. Specifically disclosed is an imino derivative represented by chemical formula (1) [wherein “Ar” represents a heterocyclic group which may have a substituent on the ring; “X” represents a sulfur atom, CH2 or NR; “R” represents a hydrogen atom or an alkyl group; “Y” represents a group selected from COR1, CONR3R4, CONHCOR5 and CO2R9; and “R1”, “R3”, “R4”, “R5” and “R9” independently represent a hydrogen atom or a specific substituent].
Patent NZ-591593-A (NZ)
Title: Optimized flavored polymeric compositions
Inventor: MACINNIS KARI L
IPC: A23L27/29
Filed: 2009-08-28
Abstract: ABSTRACT - 591593 The disclosure relates to flavored polymeric compositions for molded articles and a process thereof, wherein the flavored polymeric compositions comprises: one or more heat stable flavor enhancing agent which provides the taste component of flavor, wherein said flavor enhancing agent is selected for its ability to provide sweetness, sourness, bitterness, saltiness, coolness, umami, fatty acid, or acidity, one or more heat stable flavorant, one or more polymer(s) characterized by a capacity for providing for flavor enhancing agent and flavorant migration in a finished product, as well as being characterized by thermal stability of the flavor enhancing agent and flavorant selected from raspberry, strawberry, apple, melon, peach, peppermint, cinnamon, spearmint, range, lime, lemon, chocolate, vanilla, etc., wherein the one or more polymer(s) are selected from the group consisting of polyolefins, polyolefin copolymers or terpolymers, functionalized/modified polyolefins, polyolefin plastomers or elastomers, and thermoplastic polyolefins, which may be selected from polyethylene, polypropylene, any copolymers or terpolymers thereof, elastomers, thermoplastic elastomers, plastomers, ionomers, polybutadiene, polybutylene, polyvinyl chloride, polylactic acid, fluorinated polymers, polystyrenes, polyesters, polyamides, silicones (polymerized siloxanes), silicone rubber, rubber, latex, as well as any other thermosets or any combinations thereof., and wherein the composition optionally comprises additives selected from antioxidants, antistatics, antifogs, antimicrobials, slips, antiblocks, minerals, fillers, optical brighteners, foaming agents, nucleating agents, impact modifiers, dispersing aids, release agents, waxes, colorants, pigments, and UV stabilizers, wherein articles made from such polymeric compositions are not intended to be consumed, significantly destructed, masticated or fully or partially dissolved to release flavor, and wherein the one or more heat stable flavor enhancing agent is incorporated in the polymer(s).
Patent NZ-595746-A (NZ)
Title: System for supporting modular components wherein the support has horizontal, vertical, and diagonal grooves connectable with projections on the components
Inventor: BEKESI DAVID
IPC: E04C2/30
Filed: 2011-10-13
Abstract: Disclosed is an arrangement of supported modular components such as wall panels and tiles. The arrangement includes a support (10) in the form of a backing sheet (11) which has a front connecting face (12), and a plurality of modular components having a rear connecting face. The front and rear connecting faces co-operate to hold the faces in connection to support the modular components on the support. Cooperation between the front and rear connecting faces comprises a plurality of grooves (14) formed in the front connecting face of the support and a plurality of projections formed in the rear connecting face of the modular components. The projections of the modular components are received within the grooves of the support. A first plurality of the grooves extend parallel to each other and horizontally (15), a second plurality of the grooves extend parallel to each other and vertically (16) and a third plurality of the grooves extend parallel to each other and diagonally. The third plurality of the grooves intersects the first and second plurality of grooves.
Patent NZ-599909-A (NZ)
Title: Method for address translator traversal in 3gpp networks
Inventor: VOGT CHRISTIAN
IPC: H04L29/06
Filed: 2010-10-27
Abstract: 599909 Disclosed is a machine-implemented method for performing a network address translator traversal for a host (101) of a third generation partnership project, 3GPP, network to acquire a global Internet protocol, IP, address and a global port using existing 3GPP protocols. An ACTIVATE PACKET DATA PROTOCOL, PDP, CONTEXT REQUEST message is received at a serving gateway device (102), from a host (101). The ACTIVATE PDP CONTEXT REQUEST message is compatible with 3GPP network protocols and includes a global reachability request option that requests a global IP address and a global port to be allocated to the host (101). In response to the ACTIVATE PDP CONTEXT REQUEST message, a CREATE PDP CONTEXT REQUEST message is transmitted from the serving gateway device (102) to an Internet gateway device (103). The CREATE PDP CONTEXT REQUEST message includes the global reachability request option from the ACTIVATE PDP CONTEXT REQUEST message and the CREATE PDP CONTEXT REQUEST message is compatible with the 3GPP network protocols. A CREATE PDP CONTEXT RESPONSE message is then received at the serving gateway device (102) from the Internet gateway (103). The CREATE PDP CONTEXT RESPONSE message which is compatible with the 3GPP network protocols and includes a global reachability response option specifying therein a global IP address and a global port allocated to the host (101). In response to the CREATE PDP CONTEXT RESPONSE message, an ACTIVATE PDP CONTEXT ACCEPT message is transmitted from the serving gateway device (102) to the host (101). The ACTIVATE PDP CONTEXT ACCEPT message includes the global reachability response option from the CREATE PDP CONTEXT RESPONSE message and the ACTIVATE PDP CONTEXT ACCEPT message is compatible with the 3GPP network protocols. As a result, the host (101) does not need to establish a separate connection session to the Internet gateway device (103) in order to acquire the global IP address and the global port associated with the host (101).
Patent NZ-600309-A (NZ)
Title: Furcated composite post
Inventor: OLSSON ASHLEY DEAN
IPC: B21B1/00
Filed: 2010-11-02
Abstract: 600309 Disclosed is a roll mill for manufacturing a furcated composite post (40) which has at least two strips (46, 47) that are joined together along their length in a furcated manner. The roll mill comprises working rolls for profile rolling at least one of the strips to a desired cross section, and positioning rolls for holding the at least two strips in a correct orientation for joining. A method of manufacturing a furcated composite post is also disclosed. The method comprises the steps of feeding one or more of the strips at a set rate to working rolls of the roll mill for profile rolling to a desired cross section, feeding the strips at the same set rate to positioning rolls for holding the strips in a correct orientation for joining, and joining the strips together, preferably by welding the strips along their length. A furcated composite post manufactured by the aforementioned method is also disclosed.
Patent NZ-603644-A (NZ)
Title: Bicyclic heteroaryl kinase inhibitors and methods of use
Inventor: LOWETH COLIN J
IPC: C07D487/04
Filed: 2011-05-24
Abstract: The disclosure relates to substituted imidazo-pyrazin-one derivatives of formula (VI) having an inhibitory effect on kinases including Mixed Lineage Kinases (MLK), wherein the variables are as defined in the specification. Also disclosed are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by Mixed Lineage Kinase inhibition, wherein said disease is chosen from diabetes mellitus, hyperglycemia, retinopathy, nephropathy, neuropathy, ulcers, micro- and macroangiopathies, gout and diabetic foot disease, insulin resistance, metabolic syndrome, hyperinsulinemia, hypertension, hyperuricemia, obesity, edema, dyslipidemia, chronic heart failure, atherosclerosis, peripheral inflammation, cancer and hepatitis. Also provided are methods of treatment of neuropsychiatric disorders that comprise the inhibition of Mixed Lineage Kinases.
Patent NZ-607381-A (NZ)
Title: 5-iodo-triazole derivatives
Inventor: PORTZ DANIELA
IPC: C07D405/06
Filed: 2011-08-23
Abstract: 607381 Disclosed are 5-iodo-triazole derivatives of formula I for example 1-(4-bromophenyl)-1-(1-phenoxycyclopropyl)-2-(5-iodo-1H-1,2,4-triazol-1-yl)ethanol. Also disclosed is a method for producing said compounds, agents containing said compounds, and the use thereof as biologically active compounds, in particular for fighting harmful microorganisms in plant protection, in material protection, and as plant growth regulators.
Patent NZ-620382-A (NZ)
Title: Alkaline compositions and their dental and medical use
Inventor: ATHANASSIADIS BASIL
IPC: A61K6/884
Filed: 2012-07-27
Abstract: The present disclosure relates to antimicrobial alkaline compositions suitable for use in medical and dental treatment. The compositions comprise a polyalkylene glycol or C3-C6 polyol compound and calcium hydroxide or components that generate calcium hydroxide in situ. The use of the compositions as dental medicaments, obturants, liners, oral disinfectants and bone cements is also described.
Patent NZ-629877-A (NZ)
Title: Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
Inventor: MENON ANIL
IPC: A61P35/00
Filed: 2014-09-03
Abstract: Disclosed are crystal and amorphous forms of 1-Ethyl-7-(2-Methyl-6-(1H-1,2,4-Triazol-3-yl)Pyridin-3-yl)-3,4-Dihydropyrazino[2,3-B]Pyrazin-2(1H)-One. The solid forms of the Compound are useful for treating or preventing cancer and conditions treatable or preventable by inhibition of a kinase pathway, for example, the mTOR/PI3K/Akt pathway.
Patent NZ-710330-A (NZ)
Title: Soft tissue repair allografts and methods for preparing same
Inventor: LOCARNO MICHAEL
IPC: C12N5/071
Filed: 2014-03-13
Abstract: Allografts for soft tissue repair, including breast reconstruction and other plastic surgery procedures, are disclosed. One allograft is made from decellularized dermal tissue and constitutes a collagen matrix having substantially uniform density and porosity. Another allograft is a hybrid bilayer tissue form that is made from decellularized dermal and adipose tissues. Methods for making both allografts are also disclosed.
Patent NZ-713705-A (NZ)
Title: Control unit for controlling an automatic device for preparing beverages
Inventor: WESSELS HENDRIKUS CHRISTINUS MARIA
IPC: G06F3/048
Filed: 2010-10-08
Abstract: Disclosed is a control unit for an automatic device for preparing a beverage. The control unit is provided with a display panel and an input means which enables a user by means of designations of image elements shown on the display panel to choose from a plurality of formulations a formulation for the beverage to be prepared. The control unit is provided furthermore with an operating unit for displaying by means of the display panel a visually observable reaction to designations provided by the user, and for controlling a preparation unit of the automatic device, with an operating condition in which the display panel has selection fields for mutually exclusive settings for formulations of the beverage to be prepared. The control unit enables the user through designation of one of the selection fields to select one of the settings. A collecting field with at least one setting field shows the chosen setting of the formulation and the non-designated selection fields remain visible and selectable. The control unit enables the user to confirm a choice made, by making a dragging movement from the designated selection field to the collecting field.
Patent NZ-726911-A (NZ)
Title: Compositions and methods for treating and preventing staphylococcus aureus infections
Inventor: SIMARD JOHN
IPC: C12R1/445
Filed: 2015-06-03
Abstract: Antibodies having Fab regions that specifically bind to Staphylococcus aureus protein A are capable of mediating opsinization of Staphylococcus aureus bacteria despite their expression of antibody-neutralizing protein A. These antibodies and antigen-binding fragments thereof can be used in methods of treating and/or preventing Staphylococcus aureus infections.
Patent NZ-731580-A (NZ)
Title: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Inventor: FRITSCHE JENS
IPC: C07K7/08
Filed: 2011-03-15
Abstract: Disclosed is a use of a peptide consisting of the sequence according to SEQ ID No. 63 KIQEILTQV which is derived from IGF2BP3 or a fusion protein for producing a pharmaceutical composition for the treatment of cancer. The invention further relate to activated cytotoxic T Lymphocytes (CTL) and antibodies which are specific to the MHC/peptide complex.